We are live on ! Find out more
PLXP

PLx Pharma Inc. Common Stock
PLXP

Delisted

PLXP was delisted on the 12th of April, 2023.

Back to rankings

63 hedge funds and large institutions have $184M invested in PLx Pharma Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 26 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

340% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 5

333% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 6

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

59% more capital invested

Capital invested by funds: $116M → $184M (+$68M)

37% more funds holding

Funds holding: 46 → 63 (+17)

23% more call options, than puts

Call options by funds: $7.56M | Put options by funds: $6.14M

Holders
63
Holders Change
+17
Holders Change %
+36.96%
% of All Funds
1.1%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
22
Increased
26
Reduced
6
Closed
5
Calls
$7.56M
Puts
$6.14M
Net Calls
+$1.42M
Net Calls Change
+$3.46M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$3.45M
2
JMPWA
JP Morgan Private Wealth Advisors
California
+$3.38M
3
BlackRock
BlackRock
New York
+$3.03M
4
Jane Street
Jane Street
New York
+$3M
5
Two Sigma Investments
Two Sigma Investments
New York
+$2.94M

Top Sellers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
-$6.25M
2
MS
Maven Securities
Jersey
-$5.24M
3
Renaissance Technologies
Renaissance Technologies
New York
-$2.88M
4
AGM
Alpine Global Management
New York
-$1.08M
5
PA
Perceptive Advisors
New York
-$793K
Name Holding Trade Value Shares
Change 		Change in
Stake
Marshall Wace
26
Marshall Wace
United Kingdom
$1.09M -$6.25M -357,658 -86%
PCM
27
Prelude Capital Management
New York
$1.08M +$980K +56,052 New
SEI Investments
28
SEI Investments
Pennsylvania
$911K +$825K +47,198 New
Northern Trust
29
Northern Trust
Illinois
$827K -$28.7K -1,644 -4%
MW
30
MBL Wealth
North Carolina
$811K +$734K +42,000 New
SPIA
31
Steward Partners Investment Advisory
New York
$794K +$534K +30,555 +288%
UBS Group
32
UBS Group
Switzerland
$772K +$402K +22,986 +135%
CSS
33
Cubist Systematic Strategies
Connecticut
$751K +$680K +38,912 New
JF
34
Jump Financial
Illinois
$664K +$601K +34,400 New
IAN
35
Integrated Advisors Network
Texas
$660K +$598K +34,210 New
GSC
36
Ground Swell Capital
South Carolina
$583K +$528K +30,186 New
Commonwealth Equity Services
37
Commonwealth Equity Services
Massachusetts
$575K +$223K +12,778 +75%
PAG
38
Private Advisor Group
New Jersey
$569K +$76.9K +4,400 +18%
HWA
39
Heritage Way Advisors
Illinois
$483K -$157K -9,000 -26%
HighTower Advisors
40
HighTower Advisors
Illinois
$452K +$409K +23,409 New
EVC
41
Eidelman Virant Capital
Missouri
$342K – – –
PMAM
42
Picton Mahoney Asset Management
Ontario, Canada
$332K +$301K +17,200 New
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$271K +$101K +5,752 +69%
Fayez Sarofim & Co
44
Fayez Sarofim & Co
Texas
$265K – – –
CG
45
Cutler Group
California
$243K +$221K +12,632 New
Squarepoint
46
Squarepoint
New York
$199K +$180K +10,307 New
CWM
47
Cranbrook Wealth Management
Michigan
$145K – – –
Barclays
48
Barclays
United Kingdom
$143K +$116K +6,665 +919%
ST
49
Smithfield Trust
Pennsylvania
$98K +$89.1K +5,100 New
DWA
50
Dorsey Wright & Associates
California
$91K +$6.43K +368 +8%
1
2
3

PLXP Hedge Fund Activity: Q3 2021 in Review

63 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in PLx Pharma Inc. Common Stock (PLXP) for Q3 2021, worth a combined $184M — up 59% from $116M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new PLXP positions and 5 closed out — a net gain of 17 holders — while 26 added to existing stakes and 6 trimmed.

The largest buyer was Vanguard Group, adding an estimated $3.45M. The largest seller was Marshall Wace, cutting an estimated $6.25M.

  • 63 institutional investors held PLx Pharma Inc. Common Stock (PLXP) as of Q3 2021, up from 46 in Q2 2021.
  • Funds reported $184M of PLx Pharma Inc. Common Stock stock for Q3 2021, up 59% quarter-over-quarter.
  • 22 funds opened new PLx Pharma Inc. Common Stock positions in Q3 2021 and 5 closed out, a net change of +17 holders.
  • The largest PLx Pharma Inc. Common Stock buyer in Q3 2021 was Vanguard Group, an estimated $3.45M added.
  • The largest PLx Pharma Inc. Common Stock seller in Q3 2021 was Marshall Wace, an estimated $6.25M sold.

Based on aggregated 13F filings for Q3 2021.